| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |